138 related articles for article (PubMed ID: 10710057)
1. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease.
Rajapakse RO; Korelitz BI; Zlatanic J; Baiocco PJ; Gleim GW
Am J Gastroenterol; 2000 Mar; 95(3):684-8. PubMed ID: 10710057
[TBL] [Abstract][Full Text] [Related]
2. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.
Francella A; Dyan A; Bodian C; Rubin P; Chapman M; Present DH
Gastroenterology; 2003 Jan; 124(1):9-17. PubMed ID: 12512024
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.
Teruel C; López-San Román A; Bermejo F; Taxonera C; Pérez-Calle JL; Gisbert JP; Martín-Arranz M; Ponferrada A; Van Domselaar M; Algaba A; Estellés J; López-Serrano P; Linares PM; Muriel A
Am J Gastroenterol; 2010 Sep; 105(9):2003-8. PubMed ID: 20700117
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.
Coelho J; Beaugerie L; Colombel JF; Hébuterne X; Lerebours E; Lémann M; Baumer P; Cosnes J; Bourreille A; Gendre JP; Seksik P; Blain A; Metman EH; Nisard A; Cadiot G; Veyrac M; Coffin B; Dray X; Carrat F; Marteau P;
Gut; 2011 Feb; 60(2):198-203. PubMed ID: 21115547
[TBL] [Abstract][Full Text] [Related]
5. The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception.
Nørgård B; Pedersen L; Jacobsen J; Rasmussen SN; Sørensen HT
Aliment Pharmacol Ther; 2004 Mar; 19(6):679-85. PubMed ID: 15023170
[TBL] [Abstract][Full Text] [Related]
6. Incidence of neoplasms in patients who develop sustained leukopenia during or after treatment with 6-mercaptopurine for inflammatory bowel disease.
Disanti W; Rajapakse RO; Korelitz BI; Panagopoulos G; Bratcher J
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1025-9. PubMed ID: 16765651
[TBL] [Abstract][Full Text] [Related]
7. The ten-year single-center experience with 6-mercaptopurine in the treatment of inflammatory bowel disease.
Glazier KD; Palance AL; Griffel LH; Das KM
J Clin Gastroenterol; 2005 Jan; 39(1):21-6. PubMed ID: 15599205
[TBL] [Abstract][Full Text] [Related]
8. 6MP for fathers with IBD at the time of conception: the value of a large clinical experience over unrelated controls.
Korelitz BI; Rajapakse RO; Zlatanic J; Baiocco PJ; Gleim GW
Am J Gastroenterol; 2000 Sep; 95(9):2386-7. PubMed ID: 11007251
[No Abstract] [Full Text] [Related]
9. What's good for the goose should be good for the gander--6-MP use in fathers with inflammatory bowel disease.
Kane SV
Am J Gastroenterol; 2000 Mar; 95(3):581-2. PubMed ID: 10710042
[No Abstract] [Full Text] [Related]
10. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
[TBL] [Abstract][Full Text] [Related]
11. Complications of pregnancy and child development after cessation of treatment with 6-mercaptopurine for inflammatory bowel disease.
Zlatanic J; Korelitz BI; Rajapakse R; Kim PS; Rubin SD; Baiocco PJ; Panagopoulos G
J Clin Gastroenterol; 2003 Apr; 36(4):303-9. PubMed ID: 12642735
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
Nørgård B; Pedersen L; Christensen LA; Sørensen HT
Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
[TBL] [Abstract][Full Text] [Related]
13. Further evidence that 6-MP taken by the father with IBD provides risk of congenital anomaly to the pregnancy.
Korelitz BI; Rajapakse RO
Am J Gastroenterol; 2001 Jan; 96(1):252. PubMed ID: 11197267
[No Abstract] [Full Text] [Related]
14. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
Dubinsky MC; Feldman EJ; Abreu MT; Targan SR; Vasiliauskas EA
Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome post renal transplantation.
Sgro MD; Barozzino T; Mirghani HM; Sermer M; Moscato L; Akoury H; Koren G; Chitayat DA
Teratology; 2002 Jan; 65(1):5-9. PubMed ID: 11835226
[TBL] [Abstract][Full Text] [Related]
16. Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.
Casanova MJ; Chaparro M; Domènech E; Barreiro-de Acosta M; Bermejo F; Iglesias E; Gomollón F; Rodrigo L; Calvet X; Esteve M; García-Planella E; García-López S; Taxonera C; Calvo M; López M; Ginard D; Gómez-García M; Garrido E; Pérez-Calle JL; Beltrán B; Piqueras M; Saro C; Botella B; Dueñas C; Ponferrada A; Mañosa M; García-Sánchez V; Maté J; Gisbert JP
Am J Gastroenterol; 2013 Mar; 108(3):433-40. PubMed ID: 23318480
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease: management issues during pregnancy.
Ferrero S; Ragni N
Arch Gynecol Obstet; 2004 Sep; 270(2):79-85. PubMed ID: 12721680
[TBL] [Abstract][Full Text] [Related]
18. Medical therapy and birth outcomes in women with Crohn's disease: what should we tell our patients?
Friedman S
Am J Gastroenterol; 2007 Jul; 102(7):1414-6. PubMed ID: 17593158
[TBL] [Abstract][Full Text] [Related]
19. The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD).
Shim L; Eslick GD; Simring AA; Murray H; Weltman MD
J Crohns Colitis; 2011 Jun; 5(3):234-8. PubMed ID: 21575887
[TBL] [Abstract][Full Text] [Related]
20. Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study.
Nørgård BM; Magnussen B; Larsen MD; Friedman S
Gut; 2017 Oct; 66(10):1761-1766. PubMed ID: 27456154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
